205 related articles for article (PubMed ID: 19156136)
1. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).
Plowright L; Harrington KJ; Pandha HS; Morgan R
Br J Cancer; 2009 Feb; 100(3):470-5. PubMed ID: 19156136
[TBL] [Abstract][Full Text] [Related]
2. HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
[TBL] [Abstract][Full Text] [Related]
3. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P.
Shears L; Plowright L; Harrington K; Pandha HS; Morgan R
J Urol; 2008 Nov; 180(5):2196-201. PubMed ID: 18804814
[TBL] [Abstract][Full Text] [Related]
4. Targeting HOX and PBX transcription factors in ovarian cancer.
Morgan R; Plowright L; Harrington KJ; Michael A; Pandha HS
BMC Cancer; 2010 Mar; 10():89. PubMed ID: 20219106
[TBL] [Abstract][Full Text] [Related]
5. Targeting the HOX/PBX dimer in breast cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Gillett C; Michael A; Pandha HS
Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
[TBL] [Abstract][Full Text] [Related]
6. Targeting HOX transcription factors in prostate cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Michael A; Pandha HS
BMC Urol; 2014 Feb; 14():17. PubMed ID: 24499138
[TBL] [Abstract][Full Text] [Related]
7. Disordered expression of HOX genes in human non-small cell lung cancer.
Abe M; Hamada J; Takahashi O; Takahashi Y; Tada M; Miyamoto M; Morikawa T; Kondo S; Moriuchi T
Oncol Rep; 2006 Apr; 15(4):797-802. PubMed ID: 16525661
[TBL] [Abstract][Full Text] [Related]
8. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
Shen LY; Zhou T; Du YB; Shi Q; Chen KN
Cancer Sci; 2019 May; 110(5):1735-1745. PubMed ID: 30844117
[TBL] [Abstract][Full Text] [Related]
9. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
10. Altered HOX and WNT7A expression in human lung cancer.
Calvo R; West J; Franklin W; Erickson P; Bemis L; Li E; Helfrich B; Bunn P; Roche J; Brambilla E; Rosell R; Gemmill RM; Drabkin HA
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12776-81. PubMed ID: 11070089
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
[TBL] [Abstract][Full Text] [Related]
12. ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors.
Dasgupta P; Rizwani W; Pillai S; Davis R; Banerjee S; Hug K; Lloyd M; Coppola D; Haura E; Chellappan SP
J Natl Cancer Inst; 2011 Feb; 103(4):317-33. PubMed ID: 21212384
[TBL] [Abstract][Full Text] [Related]
13. Targeting HOX/PBX dimers in cancer.
Morgan R; El-Tanani M; Hunter KD; Harrington KJ; Pandha HS
Oncotarget; 2017 May; 8(19):32322-32331. PubMed ID: 28423659
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
[TBL] [Abstract][Full Text] [Related]
15. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
[TBL] [Abstract][Full Text] [Related]
16. SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells.
Tang X; Yang Y; Song X; Liu X; Wang X; Huang F; Li Y; Chen F; Wan H
Biochem Biophys Res Commun; 2019 Aug; 516(3):851-857. PubMed ID: 31266633
[TBL] [Abstract][Full Text] [Related]
17. miR-129-2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4.
Zhou W; Cai C; Lu J; Fan Q
Thorac Cancer; 2022 Apr; 13(7):956-964. PubMed ID: 35146917
[TBL] [Abstract][Full Text] [Related]
18. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
19. Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis.
Hwang KE; Park DS; Kim YS; Kim BR; Park SN; Lee MK; Park SH; Yoon KH; Jeong ET; Kim HR
Int J Oncol; 2013 Jul; 43(1):72-8. PubMed ID: 23615915
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA 00312 regulated by HOXA5 inhibits tumour proliferation and promotes apoptosis in Non-small cell lung cancer.
Zhu Q; Lv T; Wu Y; Shi X; Liu H; Song Y
J Cell Mol Med; 2017 Sep; 21(9):2184-2198. PubMed ID: 28338293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]